Edition:
United Kingdom

People: Collegium Pharmaceutical Inc (COLL.OQ)

COLL.OQ on NASDAQ Stock Exchange Global Select Market

10.35USD
19 Jul 2019
Change (% chg)

$-0.18 (-1.71%)
Prev Close
$10.53
Open
$10.47
Day's High
$10.55
Day's Low
$10.18
Volume
108,563
Avg. Vol
116,507
52-wk High
$21.19
52-wk Low
$10.18

Fleming, Alison 

Dr. Alison B. Fleming Ph.D., is the Executive Vice President and Chief Technology Officer of Collegium Pharmaceutical Inc. Prior to being our Chief Technology Officer, Dr. Fleming led our development team as our Vice President, Product Development since October 2002. Prior to joining us, Dr. Fleming's academic research focused on implantable drug delivery systems for cancer therapy. Dr. Fleming is an inventor on several U.S. patents and pending patent applications, and has authored numerous scientific publications and poster presentations in the field of novel drug delivery systems and abuse-deterrent opioid formulations. Dr. Fleming graduated from the University of Massachusetts, Amherst in 1997 with a B.S. in Chemical Engineering and received a Ph.D. in Chemical and Biomolecular Engineering from Cornell University in 2002.

Basic Compensation

Total Annual Compensation, USD 346,154
Restricted Stock Award, USD 608,750
Long-Term Incentive Plans, USD --
All Other, USD 954,262
Fiscal Year Total, USD 1,909,170

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Heffernan

4,694,040

Joseph Ciaffoni

3,505,300

Paul Brannelly

1,975,500

Alison Fleming

1,909,170

Shirley Kuhlmann

1,607,030

Scott Dreyer

1,976,910
As Of  31 Dec 2018